Dennis Kubrak
Publications by Year
Research Areas
Asthma and respiratory diseases, Alzheimer's disease research and treatments, Chemical Synthesis and Analysis, Respiratory and Cough-Related Research, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1(1995)149 cited
- → Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease(2008)109 cited
- → N-[(Arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure(1990)48 cited
- → Discovery of a novel series of Notch-sparing γ-secretase inhibitors(2008)25 cited
- → Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters(1987)23 cited
- → Regioselective functionalization. .beta. Substituent effects on the regioselectivity of Baeyer-Villiger oxidations of 3-substituted 2-azabicyclo[2.2.2]octan-5-ones (isoquinuclidin-5-ones)(1982)20 cited
- → N-[(Arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene d4 antagonists of novel structure(1989)19 cited
- → (S)-N-(5-Chlorothiophene-2-sulfonyl)-β,β-diethylalaninol a Notch-1-sparing γ-secretase inhibitor(2008)19 cited
- → Synthesis of [[(naphthalenylmethoxy)- and -(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors(1986)13 cited
- → Asymmetric synthesis of novel α-amino acids with β-branched side chains(2007)12 cited